Selux Diagnostics Announces Additional $48 Million in Funding
This additional funding comes at the heels of Selux announcing their third FDA 510(k) clearance on their direct from Positive Blood Culture Separator, making them...
The Selux PBC Separator With Selux AST System Receives FDA 510(k) Clearance for Rapid Antibiotic Susceptibility Testing Direct From Positive Blood Culture
The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST...
Selux Diagnostics Receives FDA Clearance on Their Gram-Negative Panel, Expanding the Antibiotic Menu for Its Next Generation Phenotyping System for Rapid AST
Approval gives way to the most comprehensive single menu offered by an AST platform while delivering precise, rapid results in 5.5 hours from isolated colonies....
Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics’ Board of Directors
Former President of BD North America brings global healthcare leadership experience as Selux launches its recently FDA-cleared NGP System for rapid antibiotic susceptibility testing. Selux...
FDA Clears ‘Selux NGP System’ for Rapid Antibiotic Susceptibility Testing
In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for...